Literature DB >> 8760099

Fluid flow stimulates rapid and continuous release of nitric oxide in osteoblasts.

D L Johnson1, T N McAllister, J A Frangos.   

Abstract

Interstitial fluid flow may mediate skeletal remodeling in response to mechanical loading. Because nitric oxide (NO) has been shown to be an osteoblast mitogen and inhibitor of osteoclastic resorption, we investigated and characterized the role of fluid shear on the release of NO in osteoblasts. Rat calvarial cells in a stationary culture produced undetectable levels of NO. Fluid shear stress (6 dyn/cm2) rapidly increased NO release rate to 9.8 nmol.h-1.mg protein-1 and sustained this production for 12 h of exposure to flow. Cytokine treatment also induced NO synthesis after a 12-h lag phase of zero production, followed by a production rate of 0.6 nmol.h-1.mg protein-1. Flow-induced NO production was blocked by the NO synthase (NOS) inhibitor NG-amino-L-arginine, but not by dexamethasone, which suggests that the flow stimulated a constitutive NOS isoform. This is the first time that a functional constitutively present NOS isoform has been identified in osteoblasts. Moreover, fluid flow represents the most potent stimulus of NO release in osteoblasts reported to date. Fluid flow-induced NO production may therefore play a primary role in bone maintenance and remodeling.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Substances:

Year:  1996        PMID: 8760099     DOI: 10.1152/ajpendo.1996.271.1.E205

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  43 in total

Review 1.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells.

Authors:  T Matsuo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress.

Authors:  Tarak Srivastava; Ellen T McCarthy; Ram Sharma; Patricia A Cudmore; Mukut Sharma; Mark L Johnson; Lynda F Bonewald
Journal:  J Cell Commun Signal       Date:  2010-04-08       Impact factor: 5.782

4.  Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces.

Authors:  Vassilios I Sikavitsas; Gregory N Bancroft; Heidi L Holtorf; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

5.  A novel ex vivo model for investigation of fluid displacements in bone after endoprosthesis implantation.

Authors:  C Gatzka; E Schneider; M L Knothe Tate; U Knothe; P Niederer; M L Knothe Tate
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

6.  Bone marrow blood vessel ossification and "microvascular dead space" in rat and human long bone.

Authors:  Rhonda D Prisby
Journal:  Bone       Date:  2014-03-27       Impact factor: 4.398

7.  In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism.

Authors:  N Lara-Castillo; N A Kim-Weroha; M A Kamel; B Javaheri; D L Ellies; R E Krumlauf; G Thiagarajan; M L Johnson
Journal:  Bone       Date:  2015-03-30       Impact factor: 4.398

Review 8.  Mechanisms by which exercise improves bone strength.

Authors:  Charles H Turner; Alexander G Robling
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

9.  Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner.

Authors:  Gregory N Bancroft; Vassilios I Sikavitsas; Juliette van den Dolder; Tiffany L Sheffield; Catherine G Ambrose; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 10.  Nitric oxide signaling in mechanical adaptation of bone.

Authors:  J Klein-Nulend; R F M van Oers; A D Bakker; R G Bacabac
Journal:  Osteoporos Int       Date:  2013-12-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.